23 Scopus citations

Abstract

This study aimed to assess whether glucose transporter 1 (GLUT1) is useful in prognostication or differential diagnosis of renal tumors. GLUT1 immunostain for 228 renal tumors showed a membranous or cytoplasmic pattern. The membranous pattern was seen in 86.2% of 145 clear cell renal cell carcinomas (RCCs) and 100% of 11 transitional cell carcinomas (TCCs) but in no oncocytomas, other subtypes of RCC, or sarcomatoid areas of RCCs. The cytoplasmic pattern was seen in 55.2% of 145 clear cell RCCs, 38% of papillary RCCs (11/29), 13% of chromophobe RCCs (2/16), 22% of oncocytomas (5/23), and 82% of TCCs (9/11). Western blot showed a markedly increased GLUT1 protein content in clear cell RCCs compared with a low level in papillary RCCs and normal kidney specimens. GLUT1 expression in clear cell RCC was not significantly correlated with patient survival, tumor grade, or tumor stage. GLUT1 may be a novel target for immunotherapy and a useful marker in the differential diagnosis and classification of renal tumors.

Original languageEnglish (US)
Pages (from-to)245-254
Number of pages10
JournalAmerican Journal of Clinical Pathology
Volume128
Issue number2
DOIs
StatePublished - Aug 2007

Keywords

  • GLUT1
  • Immunohistochemistry
  • Renal neoplasm
  • Tissue microarray
  • Transitional cell carcinoma
  • Western blot

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Fingerprint Dive into the research topics of 'Expression of GLUT1 in primary renal tumors: Morphologic and biologic implications'. Together they form a unique fingerprint.

Cite this